These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31746987)

  • 21. Oncological outcomes of sublobar resection for clinical-stage IA high-risk non-small cell lung cancer patients with a radiologically solid appearance on computed tomography.
    Hattori A; Takamochi K; Matsunaga T; Oh S; Suzuki K
    Gen Thorac Cardiovasc Surg; 2016 Jan; 64(1):18-24. PubMed ID: 26486132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor volume doubling time as a potential predictor of prognosis in clinical stage I lung squamous cell carcinoma.
    Nakahashi K; Nakatsuka M; Endo M; Shiono S
    J Thorac Dis; 2023 Jul; 15(7):3849-3859. PubMed ID: 37559608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of visceral pleural invasion in pure-solid and part-solid lung cancer patients.
    Okada S; Hattori A; Matsunaga T; Takamochi K; Oh S; Inoue M; Suzuki K
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):303-310. PubMed ID: 32918675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
    Park HL; Yoo IR; Boo SH; Park SY; Park JK; Sung SW; Moon SW
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):1021-1026. PubMed ID: 30756189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
    Ito R; Iwano S; Kishimoto M; Ito S; Kato K; Naganawa S
    Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
    Kim H; Goo JM; Suh YJ; Park CM; Kim YT
    Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fate of newly detected lesions during postoperative surveillance for non-small cell lung cancer.
    Lee JI; Lee YJ; Park KY; Park CH; Jeon YB; Choi CH; Ko KP
    Ann Thorac Surg; 2013 Jun; 95(6):1867-71. PubMed ID: 23643548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.
    Sun K; You A; Wang B; Song N; Wan Z; Wu F; Zhao W; Zhou F; Li W
    Eur Radiol; 2021 Oct; 31(10):7353-7362. PubMed ID: 33860370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
    Aktas GE; Karamustafaoğlu YA; Balta C; Süt N; Sarikaya İ; Sarikaya A
    Nucl Med Commun; 2018 Nov; 39(11):995-1004. PubMed ID: 30188416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
    Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
    Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of PET/CT uptake for peripheral clinical N0 non-small cell lung cancer.
    Wang S; Lin D; Yang X; Zhan C; Zhao S; Luo R; Wang Q; Tan L
    Cancer Med; 2020 Apr; 9(7):2445-2453. PubMed ID: 32056387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
    Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
    Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification.
    Hong JH; Park S; Kim H; Goo JM; Park IK; Kang CH; Kim YT; Yoon SH
    Korean J Radiol; 2021 Mar; 22(3):464-475. PubMed ID: 33169551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases.
    Al-Sarraf N; Gately K; Lucey J; Aziz R; Doddakula K; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):892-7. PubMed ID: 18722132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.